Rua Bioscience Limited (NZE: RUA)

Market Cap	6.87M
Revenue (ttm)	316.35K
Net Income (ttm)	-13.72M
Shares Out	159.75M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	92,856
Open	0.0450
Previous Close	0.0460
Day's Range	0.0430 - 0.0450
52-Week Range	0.0400 - 0.1630
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. It offers cannabinoid derived medicines. The company was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. Rua Bioscience Limited was founded in 2016 and is based in Gisborne, New Zealand.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: RUA

Financial Performance

In 2024, Rua Bioscience's revenue was 316,350, a decrease of -52.68% compared to the previous year's 668,484. Losses were -13.72 million, 130.2% more than in 2023.